Pharmactive advisory panel to support business development globally

Therapeutics |  News | 0 Comment | 20 Apr, 2021

Spanish Company, Pharmactive Biotech, S.L., is tapping into the pharmaceutical market with its leading branded ingredien...Read more

Singapore discovers protein that causes neurological complications in HFMD

Therapeutics |  News | 0 Comment | 20 Apr, 2021

Hand, Foot & Mouth Disease (HFMD) is a generally mild, contagious viral infection common in young children. In Singa...Read more

Japan's Terumo boosts global plasma collection and delivery platform with CSL

Therapeutics |  News | 0 Comment | 20 Apr, 2021

Terumo Blood and Cell Technologies and CSL Plasma announced a collaboration to deliver a new plasma collection platform ...Read more

Australia unveils new tool for collaborative cancer research centre

Therapeutics |  News | 0 Comment | 19 Apr, 2021

The unveiling of a new tool at the Melbourne Centre for Nanofabrication (MCN) to support ground-breaking cancer research...Read more

Japanese–European research team discovers novel genetic mitochondrial disorder

Therapeutics |  News | 0 Comment | 19 Apr, 2021

Japanese-European team of scientists, including researchers from Fujita Health University, describe mutations in the&n...Read more

Singapore develops innovative non-integrating CAR T vector system

Therapeutics |  News | 0 Comment | 16 Apr, 2021

Proteona, a Singapore-based single-cell precision medicine company, has announced the publication of the results of a lo...Read more

Japan invents novel cell therapy for type I diabetes mellitus

Therapeutics |  News | 0 Comment | 16 Apr, 2021

Researchers from The University of Tokyo have developed a novel device for the safe and effective long-term transplant...Read more

Scotland researchers deploy AI to automate tumor assessment in CT scans

Therapeutics |  News | 0 Comment | 14 Apr, 2021

Canon Medical Research Europe, a Scottish firm specializing in next-generation medical imaging software, and the Univers...Read more

Singapore studies risk of blood clot formation in COVID-19 patients

Therapeutics |  News | 0 Comment | 14 Apr, 2021

People who have recovered from COVID-19, especially those with pre-existing cardiovascular conditions, may be at risk of...Read more

Korea’s SNU Medicine bags $50K ATMI Grant by Terumo

Therapeutics |  News | 0 Comment | 12 Apr, 2021

Singapore's 'Terumo Blood and Cell Technologies' has announced its Asia Pacific Advanced Therapy Manufacturing & Inn...Read more

Korea pushes R&D of infectious disease therapeutics and vaccines

Therapeutics |  News | 0 Comment | 12 Apr, 2021

The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) have signed a memorandum of understanding...Read more

Hyundai Bioscience repurposes Niclosamide for treating intractable diseases

Therapeutics |  News | 0 Comment | 09 Apr, 2021

A research paper by a South Korean biotech company Hyundai Bioscience that demonstrated the drug repurposing of Nic...Read more

Personalized Cancer Treatment – the New Way of Treating the Patient of Tomorrow

Therapeutics |  Opinion | 0 Comment | 08 Apr, 2021

There are predictions that the number of cancer cases in Asia will keep rising, as people in this region become wealthie...Read more

Australia conducts world-first precision-based medicine therapy for brain lymphoma

Therapeutics |  News | 0 Comment | 08 Apr, 2021

An Australian research team conducted the world-first precision-based medicine therapy to cure brain lymphoma at th...Read more

International researchers identifies a globally accessible treatment strategy for COVID-19

Therapeutics |  News | 0 Comment | 01 Apr, 2021

An international research collaboration involving researchers from the National University Cancer Institute, Singapore (...Read more

AbCellera, Gilead Sciences to expedite multi-target antibody discovery programs

Therapeutics |  News | 0 Comment | 06 Apr, 2021

British Columbia-based biotechnology firm, AbCellera announced agreements to expand its collaboration with Gilead S...Read more

Singapore creates Magnesium-based bioresorbable implant technology for surgeries

Therapeutics |  News | 0 Comment | 08 Apr, 2021

SRS Life Sciences, a global company headquartered in Singapore focused on lessening disease burden across emerging natio...Read more

Daiichi Sankyo starts Ph 1 Trial for Nafamostat Inhalation Formulation to treat COVID-19

Therapeutics |  News | 0 Comment | 05 Apr, 2021

Daiichi Sankyo, based in Japan, has announced that it has initiated in Japan a first-in-human phase 1 trial for nafamost...Read more